Rapid genome-based testing is proving capable of uncovering infections that escape conventional diagnostics in children in intensive care. Using broad-range sequencing of genetic material in a patient sample, the method — known as metagenomics — can detect bacterial, viral and fungal agents in a single run and return results within the same day. Clinicians caring for critically ill paediatric patients can use these findings to refine diagnoses when standard cultures and targeted assays fail to identify a cause.
The technique analyses all nucleic acids present in a sample, matching sequences to comprehensive databases to characterise pathogens without prior assumptions about what might be present. This untargeted approach allows it to reveal uncommon organisms, mixed infections and pathogens that are difficult to grow in culture. Because it does not rely on pathogen-specific reagents, the test can be applied across a wide range of specimen types, offering a broader diagnostic reach than many traditional methods used in intensive care settings.
For bedside practice, same-day metagenomic results can inform therapeutic choices by identifying or ruling out infectious causes, potentially reducing reliance on prolonged empirical broad-spectrum antibiotics. Faster pathogen identification also supports timely infection-control measures within hospital units and can guide more precise antimicrobial stewardship. Clinical teams must, however, interpret sequencing data in the context of the patient’s condition and other laboratory findings, since detection of genetic material does not always equate to active infection.
Adoption of metagenomic testing at scale faces practical hurdles: laboratory capacity, costs, standardized workflows and the need for trained personnel to analyse complex outputs. Regulatory frameworks and consensus on clinical reporting standards will be important for routine use. Further prospective evaluations and operational studies are required to define how best to integrate same-day metagenomics into paediatric critical care pathways, determine its impact on clinical outcomes and set protocols for responsible implementation.